UNSPSC 51152302: Metoclopramide/sodium chloride

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AU300. This VA Drug Class (AU300) classifies this compound as belonging to the group PARASYMPATHOMIMETICS (CHOLINERGICS).

UNSPSC 51152302 Metoclopramide/sodium chloride is a Commodity code tagged to state and local pharmaceutical procurement, though recent opportunities show a significant mismatch between the code's nominal scope and actual buying activity. Seminole County, Florida posted IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually—neither of which are metoclopramide or sodium chloride formulations. Texas Health and Human Services Commission issued RFI HHS0017013 in April 2026 exploring direct-to-manufacturer prescription programs and vendor capacity for self-insured health plans, again without specification of particular pharmaceutical products. The code sees solicitation activity from county health departments and state HHS agencies focused on pharmaceutical supply chain management, but the recent opportunities posted under this code do not align with the metoclopramide/sodium chloride product line the code nominally describes.

The geographic spread of recent activity centers on Florida and Texas, with Seminole County's naloxone procurement requiring quarterly deliveries to its community health building in Sanford and Texas HHS conducting market intelligence for future pharmacy benefit initiatives. The naloxone solicitation carries a two-year initial term with one-year renewal option, with bidders required to meet drug-free workplace certification, E-Verify compliance, and specific insurance requirements; potential FEMA funding introduces Clean Air Act and Federal Water Pollution Control Act compliance obligations. The Texas RFI functions as an exploratory procurement mechanism without formal evaluation criteria, set-asides, or budget ranges, designed to inform future RFP strategy before commitment to specific contract amounts or durations. The code shows limited decision-relevance to firms pursuing metoclopramide or sodium chloride sales into state and local markets—the tagging appears to reflect a cataloging error rather than active pharmaceutical procurement under the code's intended scope.